A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms
- PMID: 805659
A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms
Abstract
Cyst fluid and plasma carcinoembryonic antigen (CEA) levels were measured in 11 patients with ovarian cyst-adenocarcinoma and in 16 patients with benign ovarian neoplasms. In patients with ovarian cancer, plasma CEA levels were not elevated above 2.5 ng/ml unless cyst fluid CEA levels were 4 to 16 mu-g/ml. In this series, cystic and plasma CEA levels were elevated most consistently in patients with mucinous ovarian tumors. Furthermore, on the basis of molecular size and immunoreactivity by immunodiffusion, ovarian cancer cyst fluid CEA and colonic cancer CEA had similar immunochemical properties. Consistent with the findings in other neoplasms, follow-up studies showed that plasma CEA levels returned to the normal range between 2 and 12 weeks after surgical excision of the ovarian tumor. It is concluded that plasma CEA is of value in the management of patients with ovarian mucinous cystadenocarcinoma.
Similar articles
-
Characterization of the carcinoembryonic antigen activity associated with cyst fluids of mucinous ovarian cystadenocarcinoma.Cancer Res. 1979 May;39(5):1760-5. Cancer Res. 1979. PMID: 85489
-
CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms.Ann Chir Gynaecol. 1991;80(4):368-75. Ann Chir Gynaecol. 1991. PMID: 1667567
-
Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors.Gynecol Oncol. 1986 Mar;23(3):291-303. doi: 10.1016/0090-8258(86)90129-0. Gynecol Oncol. 1986. PMID: 3514390
-
The clinical significance of carcinoembryonic antigen in the plasma and tumors of patients with gynecologic malignancies.Cancer. 1978 Sep;42(3 Suppl):1527-32. doi: 10.1002/1097-0142(197809)42:3+<1527::aid-cncr2820420826>3.0.co;2-l. Cancer. 1978. PMID: 101294 Review.
-
A case of primary mucinous cystadenocarcinoma of the appendix with elevated serum carcinoembryonic antigen (CEA).Jpn J Med. 1990 Nov-Dec;29(6):642-6. doi: 10.2169/internalmedicine1962.29.642. Jpn J Med. 1990. PMID: 2101417 Review.
Cited by
-
A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours.Br J Cancer. 1991 Jan;63(1):102-8. doi: 10.1038/bjc.1991.21. Br J Cancer. 1991. PMID: 1989647 Free PMC article.
-
Serum levels of six tumor markers in patients with benign and malignant gynecological disease.Arch Gynecol Obstet. 1988;243(2):61-8. doi: 10.1007/BF00932971. Arch Gynecol Obstet. 1988. PMID: 3401042
-
Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.Br J Cancer. 1987 Aug;56(2):153-6. doi: 10.1038/bjc.1987.175. Br J Cancer. 1987. PMID: 3117086 Free PMC article.
-
Products of gynaecological neoplasms: clinical and pathological applications.Arch Gynecol. 1980;229(4):311-23. doi: 10.1007/BF02108582. Arch Gynecol. 1980. PMID: 6158296
-
Tumour-associated trypsin inhibitor (TATI) in ovarian cancer.Br J Cancer. 1988 Mar;57(3):304-7. doi: 10.1038/bjc.1988.67. Br J Cancer. 1988. PMID: 3162682 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials